The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
getting it to the right tissues. I mean, you still have to have some sort of targeting sequence to say, "Okay, we want CRISPR." It's easier to do ex vivo when you take your blood cells. I think... Right. But saying we want to get this to the liver, or we want to get this to the heart. On muscle, yeah. That's right. Or muscle. Yeah, much more difficult.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.